• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.16% Nasdaq Up0.25%

    Taro Pharmaceutical Industries Ltd. (TARO)

    -NYSE
    147.89 Down 0.81(0.54%) Jun 1, 4:02PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 1998
    Total Revenue 13,499  
    Cost of Revenue6,046  
    Gross Profit 7,453  
    Operating Expenses
    Research Development2,275  
    Selling General and Administrative4,604  
    Non Recurring -  
    Others -  
    Total Operating Expenses -  
    Operating Income or Loss 574  
    Income from Continuing Operations
    Total Other Income/Expenses Net(565)
    Earnings Before Interest And Taxes9  
    Interest Expense -  
    Income Before Tax9  
    Income Tax Expense(66)
    Minority Interest14  
    Net Income From Continuing Ops89  
    Non-recurring Events
    Discontinued Operations -  
    Extraordinary Items -  
    Effect Of Accounting Changes -  
    Other Items -  
    Net Income 89  
    Preferred Stock And Other Adjustments -  
    Net Income Applicable To Common Shares 89  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.